The Cohorts · Quarterly vintage
Inception 2024-04-01 · 2.2 years held
Q2 2024 · Top 5.
On 2024-04-01, these 5 businesses were the 5most-undervalued names in our coverage universe by Mr. Market's protocol. We've held them, equal-weighted, since.
Q2 2024 · Top 5 · since inception
+53.9%
CAGR 21.5% annualised
S&P 500 · since inception
+46.9%
CAGR 18.9% annualised
Spread
+7.1%
This cohort has beaten the index.
Other cohorts at the same inception
The constituents.
Ranked, on the inception date, by Δ% to intrinsic value. Each holding is equal-weighted at 20.0% of the portfolio.
| Rank | Ticker | Entry price | Entry IV | Entry Δ% | Current price | Return | Contribution | |
|---|---|---|---|---|---|---|---|---|
| 1 | CVX | $144.59 | $1,425.97 | +886.2% | $173.63 | +20.1% | +4.0% | Read → |
| 2 | OXY | $63.55 | $417.03 | +556.2% | $51.82 | -18.5% | -3.7% | Read → |
| 3 | JPM | $189.62 | $1,242.91 | +555.5% | $325.22 | +71.5% | +14.3% | Read → |
| 4 | BAC | $35.63 | $203.41 | +471.0% | $56.20 | +57.8% | +11.6% | Read → |
| 5 | GOOGL | $154.12 | $879.03 | +470.3% | $368.03 | +138.8% | +27.8% | Read → |
Biggest contributors
Where the cohort earned its keep.
- GOOGL · $154.12 → $368.03+138.8%
- JPM · $189.62 → $325.22+71.5%
- BAC · $35.63 → $56.20+57.8%
Biggest detractors
Where the protocol got it wrong.
- OXY · $63.55 → $51.82-18.5%